HK1030214A1 - Phenanthroline derivatives - Google Patents
Phenanthroline derivativesInfo
- Publication number
- HK1030214A1 HK1030214A1 HK01101106A HK01101106A HK1030214A1 HK 1030214 A1 HK1030214 A1 HK 1030214A1 HK 01101106 A HK01101106 A HK 01101106A HK 01101106 A HK01101106 A HK 01101106A HK 1030214 A1 HK1030214 A1 HK 1030214A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hydrogen
- alkoxycarbonyl
- alkyl
- alkylcarbamoyl
- carbamoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/957,450 US5916898A (en) | 1997-10-24 | 1997-10-24 | Phenanthroline derivatives |
US17788898A | 1998-10-23 | 1998-10-23 | |
PCT/US1998/022704 WO1999021860A1 (en) | 1997-10-24 | 1998-10-26 | Phenanthroline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1030214A1 true HK1030214A1 (en) | 2001-04-27 |
Family
ID=26873748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01101106A HK1030214A1 (en) | 1997-10-24 | 2001-02-15 | Phenanthroline derivatives |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1027351B1 (xx) |
JP (1) | JP2003522093A (xx) |
AT (1) | ATE255581T1 (xx) |
AU (1) | AU754607B2 (xx) |
CA (1) | CA2308551C (xx) |
DE (1) | DE69820288T2 (xx) |
HK (1) | HK1030214A1 (xx) |
WO (1) | WO1999021860A1 (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030153503A1 (en) | 2001-12-06 | 2003-08-14 | Klaus Stephen J. | Methods of increasing endogenous erythropoietin (EPO) |
US8318703B2 (en) | 2001-12-06 | 2012-11-27 | Fibrogen, Inc. | Methods for improving kidney function |
EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
US7618940B2 (en) | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
WO2005007192A2 (en) * | 2003-06-06 | 2005-01-27 | Fibrogen, Inc. | Cytoprotection through the use of hif hydroxylase inhibitors |
KR20080028918A (ko) | 2005-06-15 | 2008-04-02 | 피브로겐, 인크. | 암의 치료를 위한 화합물과 방법 |
US7625927B2 (en) | 2006-02-27 | 2009-12-01 | Alcon Research, Ltd. | Method of treating glaucoma |
GB201102659D0 (en) | 2011-02-15 | 2011-03-30 | Isis Innovation | Assay |
GB201113101D0 (en) | 2011-07-28 | 2011-09-14 | Isis Innovation | Assay |
CN104974187A (zh) * | 2014-04-10 | 2015-10-14 | 吉林省博创药业有限公司 | 菲罗啉类衍生物及其制备方法和应用 |
EP3937941A4 (en) * | 2019-03-11 | 2023-07-19 | The Regents of the University of California | HYDROGELS AND THEIR METHODS OF USE |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5512031B2 (xx) * | 1972-10-31 | 1980-03-29 | ||
JPS5653678A (en) * | 1980-06-25 | 1981-05-13 | Taisho Pharmaceut Co Ltd | Preparation of 1,10-phenanthroilnes |
DE3703963A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen |
DE3703959A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
DE3703962A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
DE3707429A1 (de) * | 1987-03-07 | 1988-09-15 | Hoechst Ag | Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
-
1998
- 1998-10-26 WO PCT/US1998/022704 patent/WO1999021860A1/en active IP Right Grant
- 1998-10-26 EP EP98967153A patent/EP1027351B1/en not_active Expired - Lifetime
- 1998-10-26 DE DE69820288T patent/DE69820288T2/de not_active Expired - Lifetime
- 1998-10-26 AU AU27027/99A patent/AU754607B2/en not_active Expired
- 1998-10-26 AT AT98967153T patent/ATE255581T1/de not_active IP Right Cessation
- 1998-10-26 JP JP2000517970A patent/JP2003522093A/ja active Pending
- 1998-10-26 CA CA2308551A patent/CA2308551C/en not_active Expired - Lifetime
-
2001
- 2001-02-15 HK HK01101106A patent/HK1030214A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU754607B2 (en) | 2002-11-21 |
JP2003522093A (ja) | 2003-07-22 |
AU2702799A (en) | 1999-05-17 |
WO1999021860B1 (en) | 1999-08-05 |
CA2308551A1 (en) | 1999-05-06 |
WO1999021860A1 (en) | 1999-05-06 |
ATE255581T1 (de) | 2003-12-15 |
CA2308551C (en) | 2010-02-16 |
DE69820288T2 (de) | 2004-10-21 |
EP1027351A1 (en) | 2000-08-16 |
EP1027351B1 (en) | 2003-12-03 |
DE69820288D1 (de) | 2004-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1030214A1 (en) | Phenanthroline derivatives | |
AU5879299A (en) | Adenine derivatives | |
AU2001264474A1 (en) | Admantane derivatives | |
CA2179019A1 (fr) | Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues | |
BG106569A (en) | Purine derivatives | |
GB9307527D0 (en) | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same | |
BG106567A (en) | Purine derivatives | |
BG106289A (en) | Purine derivatives | |
BG107171A (en) | Purine derivatives | |
AU2002305143A1 (en) | Pyrazolo'1,5-a!pyridine derivatives | |
AU5438499A (en) | Pyrimidine compounds | |
HU9401515D0 (en) | New polypeptide compound and a process for prepation thereof | |
EP0163599A3 (en) | Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents | |
AU4777990A (en) | 2-aminopyrimidinone derivatives | |
IL107185A0 (en) | 25-Carboxylic acid derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
WO1992014696A3 (en) | SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES | |
HUT67661A (en) | New pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
CA2324306A1 (en) | Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof | |
MX9702203A (es) | Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida. | |
PL304893A1 (en) | Serotoninergic derivatives of ergoline | |
HK1023346A1 (en) | Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them | |
CA2010982A1 (en) | Osteogenesis promotion with use of vitamin d derivatives | |
EP0298423A3 (en) | Antibiotic ksb-1939 compounds and production process thereof as well as pesticidal agents containing same | |
AU5715894A (en) | Methotrexate derivative | |
IE893258L (en) | New 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20181025 |